Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1276 AL 1290

Advancing medicine for Alzheimer's disease: A plasma neural exosome platform

Goetzl EJ.

FASEB J. 2020 Oct;34(10):13079-13084. doi: 10.1096/fj.202001655. Epub 2020 Aug 28.

Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis

Rezabakhsh A, Rahbarghazi R, Fathi F.

Biosens Bioelectron. 2020 Nov 1;167:112511. doi: 10.1016/j.bios.2020.112511. Epub 2020 Aug 17.

Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology

Mullins AE, Kam K, Parekh A, Bubu OM, Osorio RS, Varga AW.

Neurobiol Dis. 2020 Nov;145:105054. doi: 10.1016/j.nbd.2020.105054. Epub 2020 Aug 27.

Trying to get ahead of Alzheimer disease

Mandell BF.

Cleve Clin J Med. 2020 Aug 31;87(9):517-518. doi: 10.3949/ccjm.87b.09020.

Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease

Carapelle E, Mundi C, Cassano T, Avolio C.

Int J Mol Sci. 2020 Aug 30;21(17):6279. doi: 10.3390/ijms21176279.

[Epidemiology of Alzheimer's disease: latest trends]

Dumurgier J, Sabia S.

Rev Prat. 2020 Feb;70(2):149-151.

[Alzheimer's disease: a biological disorder?]

Hugon J.

Rev Prat. 2020 Feb;70(2):152-155.

[Early diagnosis of Alzheimer's disease (with the announcement of the diagnosis)]

Ivanoiu A, Engelborghs S, Hanseeuw B.

Rev Prat. 2020 Feb;70(2):158-163.

Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer's Disease and the Blood-Brain Barrier

Semyachkina-Glushkovskaya O, Postnov D, Penzel T, Kurths J.

Int J Mol Sci. 2020 Aug 31;21(17):6293. doi: 10.3390/ijms21176293.

Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances

Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK, Basavarajappa D, Godinez A, Di Angelantonio S, Sachdev P, Salekdeh GH, Bouwman F, Graham S, Gupta V.

Prog Retin Eye Res. 2021 May;82:100899. doi: 10.1016/j.preteyeres.2020.100899. Epub 2020 Sep 2.

HLA in Alzheimer's Disease: Genetic Association and Possible Pathogenic Roles

Wang ZX, Wan Q, Xing A.

Neuromolecular Med. 2020 Dec;22(4):464-473. doi: 10.1007/s12017-020-08612-4. Epub 2020 Sep 7.

Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau

Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, Rangaraju S, Seyfried NT.

Neuropsychopharmacology. 2021 Jan;46(1):98-115. doi: 10.1038/s41386-020-00840-3. Epub 2020 Sep 8.

Alzheimer's disease and type 2 diabetes mellitus: A systematic review of proteomic studies

Diniz Pereira J, Gomes Fraga V, Morais Santos AL, Carvalho MDG, Caramelli P, Braga Gomes K.

J Neurochem. 2021 Mar;156(6):753-776. doi: 10.1111/jnc.15166. Epub 2020 Oct 7.

Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers

Peña-Bautista C, Álvarez L, Baquero M, Ferrer I, García L, Hervás-Marín D, Cháfer-Pericás C.

J Neurochem. 2021 Jun;157(6):2187-2194. doi: 10.1111/jnc.15183. Epub 2020 Sep 30.

PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients

Wang HY, Pei Z, Lee KC, Lopez-Brignoni E, Nikolov B, Crowley CA, Marsman MR, Barbier R, Friedmann N, Burns LH.

J Prev Alzheimers Dis. 2020;7(4):256-264. doi: 10.14283/jpad.2020.6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias